Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Elyssa Maufras du Châtellier

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Investment Drector - Large Venture

Sofia Dahoune

Associate

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Nicolas Dufourcq

CEO

Mailys Ferrere

Director of Large Venture Investments

Romain Fourcade

Investment Director

Paul-Francois Fournier

Executive Director, Innovation Department

Vanessa Giraud

Director of Environmental Impact Funds

Alessandro Gonella

Director

Gwenael Hamon

Investment Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Veronique Jacq

Head of Digital Venture team

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Olivier Martinez

Investment Director

Serge Mesguich

Director of FIT

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Neel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Managing Director

Bruno Villeneuve

Associate

Jean-Marie Fougeray

Senior Investment Director, Brittany

Laure Michel

Investment Director

Past deals in Nutrition

Yumgo

Series A in 2024
Yumgo is a startup focused on creating plant-based egg alternatives designed for baking and cooking. The company develops both white and yellow egg substitutes using natural vegetable proteins, ensuring that the products are free from allergens. Yumgo aims to facilitate a shift toward sustainable dietary choices by offering flavorful options that allow consumers to maintain healthy eating habits without sacrificing taste.

Metyos

Pre Seed Round in 2024
Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing individual data, such as fat levels and energy metabolism dynamics, Metyos provides users with personalized fitness and nutrition plans. Their aim is to help individuals understand how their bodies respond to various actions, enabling them to make informed choices and effectively work towards their weight goals. Through this innovative approach, Metyos empowers users to regain control over their health and wellness.

Cuure

Series A in 2022
Cuure specializes in providing personalized vitamins and supplements tailored to individual health requirements. Utilizing data from health questionnaires and DNA tests, Cuure develops customized supplement plans aimed at enhancing overall health and wellness. Their offerings combine scientific research with a personalized approach, ensuring that users receive recommendations aligned with their specific health goals and body chemistry. Additionally, the platform promotes wellness habits through a tracking application, allowing individuals to monitor their supplement intake and adapt their health practices effectively. Cuure's commitment to fair pricing and personalized solutions makes it a distinctive player in the wellness industry.

Øzers

Pre Seed Round in 2022
Øzers is a French foodtech company that specializes in creating innovative sports nutrition products using only healthy, vegan ingredients. Founded by a professional boxer and an engineer, the company collaborates with biotech engineers and medical professionals to develop its offerings. Øzers focuses on enhancing athletic performance without compromising health, providing ultra-functional edible supplements made from plant-based ingredients, including vegetable proteins, microalgae, vitamins, and minerals. By utilizing the potential of these natural components, Øzers aims to support athletes in achieving their maximum performance.

Nutripure

Private Equity Round in 2022
Nutripure is a company based in Deyme, France, focused on the development and distribution of food supplements and organic superfoods. The business offers a diverse range of products, including protein bars, whey protein shakes, and peptides, aimed at helping customers achieve their health and wellness goals. As a Digital Native Vertical Brand, Nutripure emphasizes direct engagement with consumers, ensuring accessibility and quality in its offerings.

Mé-Mé

Seed Round in 2022
Mé-Mé is a producer of organic and functional drinks and gummies combined with tree sap and matcha green tea. They offer a gustatory journey and a real energizing and well-being benefit to the contribution of vitamins and minerals from tree sap and grapes.

Agronutris

Venture Round in 2021
Agronutris is a biotechnology firm focused on rearing and transforming insects into proteins for animal nutrition and organic fertilizers. The company produces protein-rich products designed to meet the nutritional needs of various animals, particularly in the aquaculture and pet food sectors. Their offerings include insect meal with a high nutritional profile, as well as organic fertilizers like Fairtil, Ultrain, and Liboost. By leveraging bioconversion processes, Agronutris aims to contribute to sustainable practices within the agri-food industry, helping to address global food challenges while promoting environmental preservation.

Gourmey

Seed Round in 2021
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

Deinove

Post in 2020
Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Microphyt

Venture Round in 2019
Microphyt specializes in the research, development, production, and marketing of natural algae-based products aimed at enhancing health and wellness. The company focuses on creating bioactive dietary supplements that support weight loss and brain health. Utilizing an industrial-scale supply of microalgae biomass and extracts, Microphyt ensures the preservation of cell integrity while producing commercial quantities of slow-growing or biofilm-forming species. This approach enables the healthcare industry to effectively meet the demands of personal care and food products, positioning Microphyt as a key player in the market for natural health solutions.

Deinove

Post in 2019
Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Alkion BioInnovations

Grant in 2019
Alkion BioInnovations, established in March 2017, focuses on developing innovative cannabinoid and pharmaceutical active pharmaceutical ingredient (API) production through large-scale plant tissue culture. The company utilizes proprietary semi-industrial technologies to produce natural plant active ingredients for pharmaceutical applications, aiming to create disruptive nutrition, non-cosmetic oil, and agrochemical products for both the pharmaceutical and agri-food sectors. In addition to its work in cannabinoid production, Alkion is also developing a novel plant-based high-intensity protein sweetener as a sugar replacement. The company has received multiple R&D grants and awards, including those from I-lab, I-Nov, and the European Innovation Council, recognizing its contributions to biotechnology and innovation.

Alkion BioInnovations

Grant in 2016
Alkion BioInnovations, established in March 2017, focuses on developing innovative cannabinoid and pharmaceutical active pharmaceutical ingredient (API) production through large-scale plant tissue culture. The company utilizes proprietary semi-industrial technologies to produce natural plant active ingredients for pharmaceutical applications, aiming to create disruptive nutrition, non-cosmetic oil, and agrochemical products for both the pharmaceutical and agri-food sectors. In addition to its work in cannabinoid production, Alkion is also developing a novel plant-based high-intensity protein sweetener as a sugar replacement. The company has received multiple R&D grants and awards, including those from I-lab, I-Nov, and the European Innovation Council, recognizing its contributions to biotechnology and innovation.

Algama

Seed Round in 2016
Algama is a food-tech company focused on developing sustainable food solutions through the use of microalgae. Established in 2013, Algama aims to address global food challenges by harnessing the nutritional and functional properties of algae to produce plant-based alternatives to animal products, such as eggs and meat. Its innovative platform also creates emulsifiers that help food manufacturers replicate the taste and texture of traditional animal-based foods. With a vision to feed 10 billion people by 2050 while preserving the planet, Algama is dedicated to making microalgae a key resource for the future of food. The company is recognized as a world leader in this sector and is supported by a range of prominent impact investors. Algama emphasizes the importance of making its products accessible, affordable, and appealing to consumers, while continually seeking talent and innovation to advance its mission.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.